Drug name - Varithena
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7731986 | PROVENSIS | Therapeutic foam |
Nov, 2024
(2 years from now) | |
| CN1882312A | PROVENSIS | Method Of Preparing A Foam Comprising A Hardener |
Feb, 2009
(13 years ago) | |
| CN1925842A | PROVENSIS | Therapeutic Foam |
Feb, 2009
(13 years ago) | |
| CN1882311A | PROVENSIS | Method Of Preparing A Foam Comprising A Hardener |
Feb, 2009
(13 years ago) | |
| CN1960705A | PROVENSIS | Therapeutic Foam |
Nov, 2024
(2 years from now) | |
| CN1960705B | PROVENSIS | Therapeutic Foam |
Nov, 2024
(2 years from now) | |
| IN266070B | PROVENSIS | Therapeutic Foam |
Nov, 2024
(2 years from now) | |
| IN200602748P1 | PROVENSIS | Therapeutic Foam |
Nov, 2024
(2 years from now) | |
| EP1701701A1 | PROVENSIS | Methods Of Preparing A Foam Comprising A Sclerosing Agent |
Nov, 2024
(2 years from now) | |
| EP1694292A2 | PROVENSIS | Therapeutic Foam Comprising A Sclerosing Solution And A Low Quanitiy Of Gaseous Nitrogen |
Nov, 2024
(2 years from now) | |
| EP1791519B1 | PROVENSIS | Therapeutic Foams With A Sclerosant And A Viscosity-Improving Agent, Methods For Its Manufacturing |
Nov, 2024
(2 years from now) | |
| EP1701701B1 | PROVENSIS | Methods Of Preparing A Foam Comprising A Sclerosing Agent |
Nov, 2024
(2 years from now) | |
| EP1694292B2 | PROVENSIS | Therapeutic Foam Comprising A Sclerosing Solution And A Low Quantity Of Gaseous Nitrogen |
Nov, 2024
(2 years from now) | |
| EP1701701B2 | PROVENSIS | Methods Of Preparing A Foam Comprising A Sclerosing Agent |
Nov, 2024
(2 years from now) | |
| EP1791519A2 | PROVENSIS | Therapeutic Foams With A Sclerosant And A Viscosity-Improving Agent, Methods For Its Manufacturing |
Nov, 2024
(2 years from now) | |
| EP1694292B1 | PROVENSIS | Therapeutic Foam Comprising A Sclerosing Solution And A Low Quantity Of Gaseous Nitrogen |
Nov, 2024
(2 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8122917 | PROVENSIS | Apparatus and method for dispensing foam |
Sep, 2024
(1 year, 11 months from now) | |
| US7814943 | PROVENSIS | Apparatus and method for dispensing foam |
Nov, 2027
(5 years from now) | |
| US9480652 | PROVENSIS | Aerosol valve |
May, 2032
(9 years from now) | |
Drugs and Companies using POLIDOCANOL ingredient
Treatment: A method of generating an injectable foam of controlled density and bubble size
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 77.5MG/7.75ML (10MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 180MG/18ML (10MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.